Register to get unlimited access to all of Citywire’s fund manager database. Registration is free and only takes a minute.

M&G Global Dividend

Ranked 12 out of 251 in - Global Equity Income over 12 months
All calculations are in USD unless stated

Managed by

Stuart Rhodes

Stuart Rhodes was born in the UK in 1980 and graduated from Bath University with a degree in business administration. He joined M&G as an equity analyst in 2004 and in 2008 he was appointed manager of the M&G Global Dividend Fund where he uses an active stockpicking investment process based on company fundamentals and valuation. Stuart is a Chartered Finacial Analyst and has been a fund manager since 2008. Outside of work he enjoys tennis and running.

Objective

At least 70% of the Fund is invested in a range of global equities. The Fund may invest across a wide range of geographies, sectors and market capitalisations. The Fund may also invest in collective investment schemes, other transferable securities, cash, near cash, other money market securities, warrants and derivatives. The Funds exposure to global equities may be gained through the use of derivatives. Derivatives may be used for efficient portfolio management.

Showing fund performance globally. You can view performance in individual jurisdictions.

Performance

Global Equity Income over : 31/08/2017 - 31/08/2018

Total Return

Quarterly Performance

to 30/06/2018 Annual Q1 Q2 Q3 Q4
2018 -5.0% 2.1%
2017 23.0% 5.8% 2.4% 4.6% 8.5%
2016 17.2% 5.5% -1.6% 8.3% 4.2%
2015 -12.3% -0.8% 1.3% -15.4% 3.2%
2014 -3.3% 0.4% 4.8% -4.4% -3.9%
2013 26.1% 9.6% -0.1% 7.1% 7.6%
2012 16.6% 11.4% -4.3% 5.6% 3.5%
2011 -2.7% 2.8% 3.9% -15.4% 7.7%
2010 16.7% 3.1% -10.5% 15.7% 9.2%
2009 44.3% -14.4% 29.9% 20.8% 7.4%
2008 -22.9%

Month by Month Performance

Returns Vs Risk

Asset Allocation

Breakdown

31/07/2018

Top 10 Holdings

Stock Size
Methanex Corp ORD 9.19%
Imperial Brands PLC ORD 5.42%
Gibson Energy Inc ORD 4.45%
Trinseo SA ORD 4.16%
Broadcom Inc ORD 3.93%
Microsoft Corp ORD 3.59%
Arthur J Gallagher & Co ORD 3.56%
Roche Holding AG Par 3.49%
UnitedHealth Group Inc ORD 3.45%
Novartis AG ORD 2.99%
31/07/2018

Registered For Sale In

  1. Singapore
  2. Switzerland
  3. United Kingdom

Fund Info

  • Launch date18/07/2008
  • Share Class size6,237Mn
  • Base currencyGBP
  • ISIN GB00B39R2M86

Purchase Info

  • Min. initial investment500
  • Min. regular additional investment100

Charges

  • Annual management1.50%
  • Initial investment4.00%

Related News

Buyers’ Market blown-open: most popular fund managers revealed

Citywire Global takes an updated look at the fund selector favourites perennially appearing at the top of investors’ watch lists.

Beyond Buyers’ Market: the all-time most popular funds revealed

From the firm favourites to the surprise selections, Citywire Global trawls three years of fund selector picks to find the most selected strategies.

The funds powering Chatfeild-Roberts' new conservative vehicle

Jupiter chief investment officer John Chatfeild-Roberts has revealed some the funds which will power his conservative fund, scheduled for launch at the end of September.

New tool seeks to match investor risk and reward

New website InvestorBee looks at the levels of risk in different investment strategies and highlights some of the top-performing funds.

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in USD).